Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

August/September 2001

Volume 10, Issue 5

Pages 361–482

  1. Introductions

    1. Top of page
    2. Introductions
    3. Original Reports
    4. ISPE Commentaries
    5. Current Awareness
  2. Original Reports

    1. Top of page
    2. Introductions
    3. Original Reports
    4. ISPE Commentaries
    5. Current Awareness
    1. Health care data and health: from numbers to outcomes (pages 363–366)

      William L. Roper and Sue Tolleson-Rinehart

      Version of Record online: 4 OCT 2001 | DOI: 10.1002/pds.605

    2. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on therapeutics (pages 373–377)

      Richard Platt, Robert Davis, Jonathan Finkelstein, Alan S. Go, Jerry H. Gurwitz, Douglas Roblin, Stephen Soumerai, Dennis Ross-Degnan, Susan Andrade, Michael J. Goodman, Brian Martinson, Marsha A. Raebel, David Smith, Marianne Ulcickas-Yood and K. Arnold Chan

      Version of Record online: 14 DEC 2001 | DOI: 10.1002/pds.607

    3. The role of databases in drug postmarketing surveillance (pages 407–410)

      Evelyn M. Rodriguez, Judy A. Staffa and David J. Graham

      Version of Record online: 14 DEC 2001 | DOI: 10.1002/pds.615

    4. A claims data approach to defining an episode of care (pages 417–427)

      Kevin A. Schulman, K. Robin Yabroff, Janet Kong, Karen F. Gold, L. Elizabeth Rubenstein, Andrew J. Epstein and Henry Glick

      Version of Record online: 14 DEC 2001 | DOI: 10.1002/pds.673

  3. ISPE Commentaries

    1. Top of page
    2. Introductions
    3. Original Reports
    4. ISPE Commentaries
    5. Current Awareness
  4. Current Awareness

    1. Top of page
    2. Introductions
    3. Original Reports
    4. ISPE Commentaries
    5. Current Awareness

SEARCH

SEARCH BY CITATION